Barriers, potential solutions, and alternatives to randomized clinical trials in male reproductive medicine

Inklings

0
0

Volume 111, Issue 5, Pages 871–872

Authors:

Joshua A. Halpern, M.D., M.S., Robert E. Brannigan, M.D.

Abstract:

The field of reproductive medicine is enjoying a renaissance in advancement and innovation, as the evolution of laboratory techniques, genetic medicine, and assisted reproductive technologies (ART) have dramatically enhanced the quality of care and outcomes for patients with subfertility. From microfluidics to home semen testing, invention has rendered this an exciting time in the study of male reproductive medicine. Yet as pioneers continue to push the envelope, there remains an incomplete trail of evidence, hampering our ability to utilize these advancements in a way that will optimally serve our patients. The pace of innovation has surpassed our ability to consistently provide robust evidence for its implementation.


Read the full text here.


Medium untitled 1

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.